The success of Sildenafil initially fueled a surge for the drug industry, nevertheless recent changes present a complicated scenario for shareholders. Lower-cost competitors are eroding revenue, and ongoing patent https://kallumyatr149070.develop-blog.com/49059862/sildenafil-and-big-pharma-a-precarious-investment